アリゾナ州における卵巣がんの臨床試験
アリゾナ州内の拠点で、卵巣がんに関する26件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- CTCA at Western Regional Medical Center, Goodyear
- Kingman Regional Medical Center, Kingman
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Gilbert
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0143 - HonorHealth, Phoenix
- Site 0102 - University of Arizona Cancer Center, Tucson
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT05128825Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Mayo Clinic, Phoenix
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/29更新 · NCT05051722DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Banner Health, Gilbert
- Mayo Clinic Hospital, Phoenix
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- HonorHealth, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- University of Arizona Cancer Center, Tucson
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- HonorHealth, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- University of Arizona Cancer Center, Tucson
被験者募集中第3相
18歳以上 · 女性 · 2026/08/26更新 · NCT05281471A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
- Site 0107, Phoenix
被験者募集中第3相
18歳以上 · 女性 · 2026/08/12更新 · NCT07546500A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Cancer Center at Saint Joseph's, Phoenix
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR HonorHealth, Phoenix
- USOR Arizona Oncology Associates, Tucson
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Mayo Clinic (Arizona), Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068AOH1996 for the Treatment of Refractory Solid Tumors
- Honor Health Research and Innovation Institute, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/28更新 · NCT05227326Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #108, Goodyear
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06545942Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
- Mayo Clinic Arizona, Phoenix
被験者募集中第3相
18歳以上 · 女性 · 2026/07/14更新 · NCT05804370A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Mayo Clinic Comprehensive Cancer Center, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05377996A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Banner Health, Gilbert
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
- Mayo Clinic in Arizona, Scottsdale
被験者募集中第1相
18歳以上 · 女性 · 2026/03/16更新 · NCT06483048A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Mayo Clinic Hospital, Phoenix
- SCRI - Arizona Oncology Associates, PC-HOPE, Tucson
被験者募集中第2相
18歳以上 · 女性 · 2025/12/23更新 · NCT06690775SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。